U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883460) titled 'Improving Combined PET/CT and MRI of the Breast Using Dedicated Breast Positioning and Imag... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07882472) titled 'A Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants.' on... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883642) titled 'Traditional Chinese Medicine Treatment for Capecitabine-Related Hand-Foot Syndrome' on Oct.... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07884240) titled 'A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacteri... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883889) titled 'Comparison of Three Osteotomy Techniques in Temporomandibular Joint Ankylosis Surgery' on O... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07882303) titled 'Native T1 Mapping and ECV in Chronic Hemolytic Anemia' on Oct. 13. Brief Summary: This cro... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07884318) titled 'Long-term Safety Study Following to JRM-001 Treatment in Pediatric Patients With Congenital... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883226) titled 'A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerab... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883720) titled 'EXercise-induced PhysioLogical Adaptations In Neurological Disorders' on Sept. 03. Brief S... Read More
U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07882056) titled 'SBRT Combined With Iparomlimab and Tuvonralimab (QL1706) and Bevacizumab for Hepatocellular... Read More